Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Blocks With Ropivacaine Infusion vs Liposomal Bupivacaine for Pain Control After Renal Transplant
NCT03737604Phase 4Active, not recruiting
- Sponsor
- University of California, Davis
- Start
- Oct 2018
- Primary completion
- Sep 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine, liposomal bupivacaine in postoperative pain, sponsored by University of California, Davis. Started Oct 2018; status: active, not recruiting.
02
Drugs
ropivacaineliposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03737604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03737604.